All registrations will be reviewed in April, and confirmations will be issued accordingly. The organizers reserve the right to approve or decline registrations to maintain the focus and quality of the event.
Participation is limited to professionals from biotech companies, pharmaceutical organizations, and investment funds.
ACCESS ASIA Bio Members are pre-confirmed as event attendees.
For inquiries or information on ACCESS ASIA Bio Membership, please contact:
Wendi Xiang | wxiang@yafocapital.com
Inquiry
For partnership inquiries or general questions regarding the event. Please contact the person below or submit an inquiry form:
Wendi Xiang | wxiang@yafocapital.com
Follow us and be updated!
ENGAGE ASIA’S BIOTECH DEALFLOW
For Global Pharma & Investors
The ACCESS ASIA Spring BD Salon & Reception 2026 provides a curated setting to connect with Asia-based biotech innovators and explore emerging partnership opportunities.
Attendees gain visibility into innovative assets and engage directly with founders, pharma leaders, and investors shaping cross-border collaboration.
👉 In-person participation enables deeper dialogue and strategic relationship building.
For Asia-Based Biotech Innovators
The salon offers innovators an opportunity to connect with global pharmaceutical partners and investors seeking new assets and collaborations.
Participants gain exposure to senior decision-makers and can signal interest in potential partnerships.
👉 ACCESS ASIA creates a focused platform for meaningful BD engagement.
BioToChina.org 